Procaps Group SA (PROC)
2.95
+0.37
(+14.34%)
USD |
NASDAQ |
May 17, 16:00
2.95
0.00 (0.00%)
After-Hours: 20:00
Procaps Group Price to Book Value: 7.620 for May 17, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 17, 2024 | 7.620 |
| May 16, 2024 | 7.391 |
| May 15, 2024 | 7.419 |
| May 14, 2024 | 7.878 |
| May 13, 2024 | 7.878 |
| May 10, 2024 | 7.792 |
| May 09, 2024 | 7.906 |
| May 08, 2024 | 7.792 |
| May 07, 2024 | 7.849 |
| May 06, 2024 | 8.050 |
| May 03, 2024 | 8.078 |
| May 02, 2024 | 8.508 |
| May 01, 2024 | 7.949 |
| April 30, 2024 | 7.505 |
| April 29, 2024 | 7.476 |
| April 26, 2024 | 7.812 |
| April 25, 2024 | 7.812 |
| April 24, 2024 | 7.877 |
| April 23, 2024 | 7.878 |
| April 22, 2024 | 7.763 |
| April 19, 2024 | 7.763 |
| April 18, 2024 | 7.734 |
| April 17, 2024 | 7.677 |
| April 16, 2024 | 7.333 |
| April 15, 2024 | 7.448 |
| Date | Value |
|---|---|
| April 12, 2024 | 7.706 |
| April 11, 2024 | 7.708 |
| April 10, 2024 | 7.591 |
| April 09, 2024 | 7.448 |
| April 08, 2024 | 7.591 |
| April 05, 2024 | 8.164 |
| April 04, 2024 | 8.164 |
| April 03, 2024 | 8.021 |
| April 02, 2024 | 7.964 |
| April 01, 2024 | 8.336 |
| March 28, 2024 | 8.308 |
| March 27, 2024 | 7.964 |
| March 26, 2024 | 8.597 |
| March 25, 2024 | 8.594 |
| March 22, 2024 | 8.894 |
| March 21, 2024 | 8.894 |
| March 20, 2024 | 8.894 |
| March 19, 2024 | 9.138 |
| March 18, 2024 | 9.310 |
| March 15, 2024 | 8.995 |
| March 14, 2024 | 8.995 |
| March 13, 2024 | 9.014 |
| March 12, 2024 | 8.622 |
| March 11, 2024 | 9.310 |
| March 08, 2024 | 8.995 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
6.245
Minimum
Oct 23 2023
93.22
Maximum
Apr 04 2023
26.76
Average
13.21
Median
Aug 22 2023
Price to Book Value Benchmarks
| Alvotech | -- |
| Moolec Science SA | 6.744 |
| Perspective Therapeutics Inc | 4.333 |
| Electromed Inc | 3.333 |
| Xtant Medical Holdings Inc | 1.967 |
Price to Book Value Related Metrics
| PS Ratio | 0.6533 |
| Price to Free Cash Flow | 7.942 |
| Price | 2.95 |
| Earnings Yield | 19.55% |
| Market Cap | 300.11M |
| Operating PE Ratio | 8.296 |
| Normalized PE Ratio | 86.17 |